Bolder BioPATH
is a Colorado-based contract pharmacology and pathology company that provides in vitro, model development, bioanalysis and related services... Read moreBolder BioPATH
is a Colorado-based contract pharmacology and pathology company that provides in vitro, model development, bioanalysis and related services... Read more
News
May 07, 2021
MarketScreener
Bolder BioPATH: Inotiv : Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc
Jul 15, 2020
BioSpace
Bolder Biopath: Sinclair Research Announces Strategic Partnership with Bolder BioPATH to Expand Early-stage Discovery Model Portfolio
Mar 20, 2020
Bolder Biopath Blog
Bolder Biopath Blog Covid-19 Response as Operations Continue
Dec 02, 2019
Bolder Biopath Blog
Bolder Biopath Blog Please come join us at the Keystone Symposia on Tissue Immunity (Jan 26-29, 2020 in Boulder, CO)
Oct 08, 2019
Bolder Biopath Blog
Bolder Biopath Blog Exciting Changes Coming in 2020!
May 02, 2017
Bolder Biopath Blog
Bolder Biopath Blog A Novel ROR-Gamma Inhibitor (VPR-254) Attenuates Key Parameters of Innate Immune Colitis in Mice
Mar 14, 2017
Bolder Biopath Blog
Bolder Biopath Blog AAALAC Accreditation
Jan 24, 2017
Bolder Biopath Blog
Bolder Biopath Blog OARSI 2017 World Congress on Osteoarthritis
Dec 22, 2016
Bolder Biopath Blog
Bolder Biopath Blog Digestive Disease Week Conference, May 6-9
Aug 25, 2016
Bolder Biopath Blog
Bolder Biopath Blog Important Things to Know About Intra-Articular Testing of Drugs in Animals - ACT's 37th Annual Meeting
